Back to Search
JESSICA GUH, MD
MD
Family Medicine Physician
NPI: 1851652135IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD60467205(WA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF MICHIGAN MEDICAL SCHOOL
Class of 2008
Research & Publications (20)
Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan.
PMID 17472844·Am J Kidney Dis·2007
4-observational
Betel-quid use is associated with the risk of the metabolic syndrome in adults.
PMID 16762942·Am J Clin Nutr·2006
8-other
Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
PMID 14633126·Kidney Int·2003
8-other
Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
PMID 12046038·Am J Kidney Dis·2002
8-other
Significance of salivary epidermal growth factor in peptic ulcer disease in hemodialysis patients.
PMID 11244307·Nephron·2001
8-other
Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1.
PMID 11684565·Am J Kidney Dis·2001
7-preclinical
Effects of ouabain on tension response and [3H]noradrenaline release in human prostate.
PMID 10604386·J Urol·2000
8-other
Moscatilin repressed lipopolysaccharide-induced HIF-1alpha accumulation and NF-kappaB activation in murine RAW264.7 cells.
PMID 19487987·Shock·2010
7-preclinical
Effects of nitric oxide and antioxidants on advanced glycation end products-induced hypertrophic growth in human renal tubular cells.
PMID 19553346·Toxicol Sci·2009
8-other
Arecoline-induced phosphorylated p53 and p21(WAF1) protein expression is dependent on ATM/ATR and phosphatidylinositol-3-kinase in clone-9 cells.
PMID 19343784·J Cell Biochem·2009
7-preclinical
Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors.
PMID 18832104·Endocrinology·2009
7-preclinical
Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells.
PMID 19466993·Br J Pharmacol·2009
8-other
Evodiamine represses hypoxia-induced inflammatory proteins expression and hypoxia-inducible factor 1alpha accumulation in RAW264.7.
PMID 19106818·Shock·2009
7-preclinical
Slowing renal function decline in chronic kidney disease patients after nephrology referral.
PMID 19019170·Nephrology (Carlton)·2008
4-observational
Mana-Hox displays anticancer activity against prostate cancer cells through tubulin depolymerization and DNA damage stress.
PMID 18663430·Naunyn Schmiedebergs Arch Pharmacol·2008
8-other
YC-1 induces apoptosis of human renal carcinoma A498 cells in vitro and in vivo through activation of the JNK pathway.
PMID 18641674·Br J Pharmacol·2008
7-preclinical
Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-kappaB activity in vascular smooth-muscle cells.
PMID 18663431·Naunyn Schmiedebergs Arch Pharmacol·2008
7-preclinical
Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells.
PMID 18607570·Naunyn Schmiedebergs Arch Pharmacol·2008
7-preclinical
Effect of taurine on advanced glycation end products-induced hypertrophy in renal tubular epithelial cells.
PMID 18834896·Toxicol Appl Pharmacol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 550 16TH AVE STE 100
SEATTLE, WA 98122 - Phone
- (206) 320-2484
Quick Facts
- NPI
- 1851652135
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile